Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Relationship between timed 25-foot walk and diffusion tensor imaging in multiple sclerosisSylvia Klineova, Rebecca Farber, Catarina Saiote, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 8, 2025
Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS studyVictoria M Leavitt, Robert Fox, Jop Mostert, et al.
Annals of Neurology|February 21, 2013
Randomized study combining interferon and glatiramer acetate in multiple sclerosisFred D Lublin, Stacey S Cofield, Gary R Cutter, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 yearsFred D Lublin, Stacey S Cofield, Gary R Cutter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 24, 2017
Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trialChristopher LaGanke, Lawrence Samkoff, Keith Edwards, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2011
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosisJ Theodore Phillips, Gavin Giovannoni, Fred D Lublin, et al.
Neuroimage. Clinical|November 2, 2013
Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center studyPonnada A Narayana, Koushik A Govindarajan, Priya Goel, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 13, 2019
Lymphocyte counts and infection rates: Long-term fingolimod treatment in primary progressive MSEdward J Fox, Fred D Lublin, Jerry S Wolinsky, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 23, 2020
Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosisGuy Buckle, Daniel Bandari, Jeffrey Greenstein, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2019
Brain and lesion segmentation in multiple sclerosis using fully convolutional neural networks: A large-scale studyRefaat E Gabr, Ivan Coronado, Melvin Robinson, et al.
Pageof 13